Louise St-Onge is the Head of Market Access and Government Affairs at Mitsubishi Tanabe Pharma Canada. She holds >25 years executive experience track record of strong contribution and achievement of commercial objectives in rare diseases, specialty therapeutic areas within both startup biotech and large pharma. Experienced in Sales, Marketing, Market Access & Government Affairs, including several product launches she brings to the table a broad perspective. Louise is recognized for her strong leadership capabilities in guiding diverse teams/groups and she bares a solid business acumen that allows her to look at problems from multiple points of view and formulate ideas that have not previously been tested.
Agenda: Day 1 Oct 5, 2020
IS RWE TRULY THE PANCEA WE ALL THINK IT IS/WILL BE?
RWE (real world evidence) has been hailed by many as the ‘magic bullet’ the industry – and Canadians overall – have been looking for to speed up access to market for new medicines. But is it? Bring back learnings from other jurisdictions such as the UK to optimize your upcoming PLA’s. Share your company’s thoughts on topics including:
Agenda: Day 2 Oct 6, 2020